Cindy Perettie and Chris McDonald outline Kite ’ s journey to world-class lymphoma treatment and sustainable , fast-paced manufacturing and delivery
KITE , A GILEAD COMPANY
Cindy Perettie and Chris McDonald outline Kite ’ s journey to world-class lymphoma treatment and sustainable , fast-paced manufacturing and delivery
Gilead ’ s vision is to create a healthier world for all people , a vision that includes sustainability as a key responsibility throughout the value chain . The ability to incorporate sustainable business practices while executing complex scientific processes is one attribute that makes Gilead and Kite so unique . This sustainability focus is embedded across all of Gilead and Kite manufacturing operations ; from integrating the 12 principles of green chemistry throughout the small molecule development process to Kite ’ s focus on innovative cell therapy treatments for blood cancers .
Lymphoma is a blood cancer that impacts 80,000 people a year globally and there are currently over 100 therapies approved for its treatment . For decades , lymphoma was treated the same way , but in recent years , a new treatment option for patients harnessing the power of their own immune system to fight cancer has emerged : CAR T-cell therapy , or CAR T . Unlike many other cancer therapies , CAR T-cell therapies are one-time treatments with curative potential that allow many patients with certain blood cancers to live longer , healthier lives .
Kite is a pioneer in the CAR T-cell therapy field and committed to changing the future of cancer treatment . sustainabilitymag . com 53